Main > ONCOLOGY (**) > Lung>NSCLC>Non-Squamous>MET EGFR->+ > TREAT.: > Co: USA. M. PembrolizuMAb Inj.

---

Co: USA. M. PembrolizuMAb Inj.'s subsections
(*) EU Approval Date: 2018. 09.10
(*) USA Approval Date: 2018. 08.20
+Pemetrexed+Pt CT
>or ALK-
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2018. 10.30.
TradeMark
TradeMark Web-Site

Co: USA. M. PembrolizuMAb Inj.'s products
This section has no products